These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31745697)

  • 1. Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study.
    Rogiers A; Leys C; De Cremer J; Awada G; Schembri A; Theuns P; De Ridder M; Neyns B
    Support Care Cancer; 2020 Jul; 28(7):3267-3278. PubMed ID: 31745697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab.
    Rogiers A; Leys C; Lauwyck J; Schembri A; Awada G; Schwarze JK; De Cremer J; Theuns P; Maruff P; De Ridder M; Bernheim JL; Neyns B
    J Immunol Res; 2020; 2020():2192480. PubMed ID: 32775464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma.
    Petrella TM; Robert C; Richtig E; Miller WH; Masucci GV; Walpole E; Lebbe C; Steven N; Middleton MR; Hille D; Zhou W; Ibrahim N; Cebon J
    Eur J Cancer; 2017 Nov; 86():115-124. PubMed ID: 28987768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma.
    Schadendorf D; Dummer R; Hauschild A; Robert C; Hamid O; Daud A; van den Eertwegh A; Cranmer L; O'Day S; Puzanov I; Schachter J; Blank C; Salama A; Loquai C; Mehnert JM; Hille D; Ebbinghaus S; Kang SP; Zhou W; Ribas A
    Eur J Cancer; 2016 Nov; 67():46-54. PubMed ID: 27596353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive outcomes in long-term survivors of Wilms tumor: a report from the St. Jude Lifetime Cohort.
    Tonning Olsson I; Brinkman TM; Hyun G; Banerjee P; Mulrooney DA; Huang IC; Green DM; Srivastava D; Robison LL; Hudson MM; Krull KR
    J Cancer Surviv; 2019 Aug; 13(4):570-579. PubMed ID: 31243647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life and psychological distress among cancer survivors in Southeast Asia: results from a longitudinal study in eight low- and middle-income countries.
    ACTION Study Group
    BMC Med; 2017 Jan; 15(1):10. PubMed ID: 28081724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life and psychological distress among cancer survivors in a middle-income country.
    Subramaniam S; Kong YC; Chinna K; Kimman M; Ho YZ; Saat N; Malik RA; Taib NA; Abdullah MM; Lim GC; Tamin NI; Woo YL; Chang KM; Goh PP; Yip CH; Bhoo-Pathy N
    Psychooncology; 2018 Sep; 27(9):2172-2179. PubMed ID: 29856903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A supportive care intervention for people with metastatic melanoma being treated with immunotherapy: a pilot study assessing feasibility, perceived benefit, and acceptability.
    Lacey J; Lomax AJ; McNeil C; Marthick M; Levy D; Kao S; Nielsen T; Dhillon HM
    Support Care Cancer; 2019 Apr; 27(4):1497-1507. PubMed ID: 30392112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
    Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer.
    Mazieres J; Kowalski D; Luft A; Vicente D; Tafreshi A; Gümüş M; Laktionov K; Hermes B; Cicin I; Rodríguez-Cid J; Wilson J; Kato T; Ramlau R; Novello S; Reddy S; Kopp HG; Piperdi B; Li X; Burke T; Paz-Ares L
    J Clin Oncol; 2020 Jan; 38(3):271-280. PubMed ID: 31751163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durable Complete Response After Discontinuation of Pembrolizumab in Patients With Metastatic Melanoma.
    Robert C; Ribas A; Hamid O; Daud A; Wolchok JD; Joshua AM; Hwu WJ; Weber JS; Gangadhar TC; Joseph RW; Dronca R; Patnaik A; Zarour H; Kefford R; Hersey P; Zhang J; Anderson J; Diede SJ; Ebbinghaus S; Hodi FS
    J Clin Oncol; 2018 Jun; 36(17):1668-1674. PubMed ID: 29283791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors.
    O'Reilly A; Hughes P; Mann J; Lai Z; Teh JJ; Mclean E; Edmonds K; Lingard K; Chauhan D; Lynch J; Au L; Ludlow A; Pattison N; Wiseman T; Turajlic S; Gore M; Larkin J; Husson O
    Support Care Cancer; 2020 Feb; 28(2):561-570. PubMed ID: 31089820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression, anxiety and quality of life in long-term survivors of malignant melanoma: a register-based cohort study.
    Beutel ME; Fischbeck S; Binder H; Blettner M; Brähler E; Emrich K; Friedrich-Mai P; Imruck BH; Weyer V; Zeissig SR
    PLoS One; 2015; 10(1):e0116440. PubMed ID: 25615573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpreting European Organisation for Research and Treatment for Cancer Quality of life Questionnaire core 30 scores as minimally importantly different for patients with malignant melanoma.
    Musoro JZ; Bottomley A; Coens C; Eggermont AM; King MT; Cocks K; Sprangers MA; Groenvold M; Velikova G; Flechtner HH; Brandberg Y;
    Eur J Cancer; 2018 Nov; 104():169-181. PubMed ID: 30359910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health related quality of life and psychosocial function among patients with carcinoid tumours. A longitudinal, prospective, and comparative study.
    Fröjd C; Larsson G; Lampic C; von Essen L
    Health Qual Life Outcomes; 2007 Apr; 5():18. PubMed ID: 17428340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of quality of life and psychological distress after inpatient cancer rehabilitation : Results of a longitudinal observational study.
    Riedl D; Giesinger JM; Wintner LM; Loth FL; Rumpold G; Greil R; Nickels A; Licht T; Holzner B
    Wien Klin Wochenschr; 2017 Oct; 129(19-20):692-701. PubMed ID: 28916897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fertility under uncertainty: exploring differences in fertility-related concerns and psychosocial aspects between breast cancer survivors and non-cancer infertile women.
    Bártolo A; Neves M; Carvalho B; Reis S; Valério E; Santos IM; Monteiro S
    Breast Cancer; 2020 Nov; 27(6):1177-1186. PubMed ID: 32583350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629.
    Hughes BGM; Mendoza RG; Basset-Seguin N; Vornicova O; Schachter J; Joshi A; Meyer N; Grange F; Piulats JM; Bauman JR; Chirovsky D; Zhang P; Gumuscu B; Swaby RF; Grob JJ
    Dermatol Ther (Heidelb); 2021 Oct; 11(5):1777-1790. PubMed ID: 34558040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report.
    Stefanski KJ; Anixt JS; Goodman P; Bowers K; Leisenring W; Scott Baker K; Burns K; Howell R; Davies S; Robison LL; Armstrong GT; Krull KR; Recklitis C
    J Natl Cancer Inst; 2021 Apr; 113(4):481-495. PubMed ID: 32797189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.